======= DHTKD1 ======= == Gene Information == * **Official Symbol**: DHTKD1 * **Official Name**: dehydrogenase E1 and transketolase domain containing 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55526|55526]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q96HY7|Q96HY7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=DHTKD1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DHTKD1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/614984|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a component of a mitochondrial 2-oxoglutarate-dehydrogenase-complex-like protein involved in the degradation pathways of several amino acids, including lysine. Mutations in this gene are associated with 2-aminoadipic 2-oxoadipic aciduria and Charcot-Marie-Tooth Disease Type 2Q. [provided by RefSeq, May 2013]. * **UniProt Summary**: The 2-oxoglutarate dehydrogenase complex catalyzes the overall conversion of 2-oxoglutarate to succinyl-CoA and CO(2). It contains multiple copies of three enzymatic components: 2- oxoglutarate dehydrogenase (E1), dihydrolipoamide succinyltransferase (E2) and lipoamide dehydrogenase (E3) (By similarity). {ECO:0000250}. |Transket pyr| |E1 dh| |oxoglutarate dehydrogenase (succinyl-transferring) activity| |thiamine pyrophosphate binding| |oxoglutarate dehydrogenase complex| |tricarboxylic acid cycle| |glycolytic process| |ATP generation from ADP| |ADP metabolic process| |nucleoside diphosphate phosphorylation| |purine ribonucleoside diphosphate metabolic process| |nucleotide phosphorylation| |purine nucleoside diphosphate metabolic process| |ribonucleoside diphosphate metabolic process| |pyruvate metabolic process| |aerobic respiration| |nucleoside diphosphate metabolic process| |hematopoietic progenitor cell differentiation| |carbohydrate catabolic process| |cellular respiration| |ATP metabolic process| |energy derivation by oxidation of organic compounds| |purine ribonucleotide metabolic process| |ribonucleotide metabolic process| |purine nucleotide metabolic process| |ribose phosphate metabolic process| |purine-containing compound metabolic process| |mitochondrial matrix| |generation of precursor metabolites and energy| |nucleotide metabolic process| |nucleoside phosphate metabolic process| |carbohydrate metabolic process| |monocarboxylic acid metabolic process| |nucleobase-containing small molecule metabolic process| |hemopoiesis| |hematopoietic or lymphoid organ development| |immune system development| |organophosphate metabolic process| |carboxylic acid metabolic process| |oxidation-reduction process| |oxoacid metabolic process| |organic acid metabolic process| |carbohydrate derivative metabolic process| |mitochondrion| |phosphorylation| |small molecule metabolic process| |organic substance catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp182|IU1-47 25μM R04 exp182]]|-1.87| |[[:results:exp237|NN-Diethyl-meta-toluamide 100μM R05 exp237]]|-1.8| |[[:results:exp260|ABT-702 0.1μM R06 exp260]]|-1.75| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12154 * **Expression level (log2 read counts)**: 5.8 {{:chemogenomics:nalm6 dist.png?nolink |}}